Cargando…

SPRR3, a novel miR-338-3p target, regulates the malignant progression of clear cell renal cell carcinoma in vitro via the PI3K/Akt signaling pathway

Clear cell renal cell carcinoma (ccRCC) is the most common type of renal cell carcinoma and has a poor prognosis. However, its underlying mechanisms remain unclear. The present study aimed to evaluate the role of small proline-rich repeat protein 3 (SPRR3) in the proliferation, migration and invasio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Man, Guo, Qiaoyan, Liu, Xianjun, Wu, Linlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943802/ https://www.ncbi.nlm.nih.gov/pubmed/35350667 http://dx.doi.org/10.3892/etm.2022.11246

Ejemplares similares

miR-338-3p suppresses the malignancy of T-cell lymphoblastic lymphoma by downregulating HOXA3
por: Wang, Li, et al.
Publicado: (2019)

Dysregulation of SPRR3/miR-876-3p Axis Contributes to Tumorigenesis in Non-Small-Cell Lung Cancer
por: Li, Qin, et al.
Publicado: (2020)

miR-338-3p Plays a Significant Role in Casticin-Induced Suppression of Acute Myeloid Leukemia via Targeting PI3K/Akt Pathway
por: Yu, Kewei, et al.
Publicado: (2022)

Expression of SPRR3 is associated with tumor cell proliferation and invasion in glioblastoma multiforme
por: LIU, QINGYANG, et al.
Publicado: (2014)

TUC338 Promotes Diffuse Large B Cell Lymphoma Growth via Regulating EGFR/PI3K/AKT Signaling Pathway
por: Li, Yan, et al.
Publicado: (2021)

piRNA-31115 Promotes Cell Proliferation and Invasion via PI3K/AKT Pathway in Clear Cell Renal Carcinoma
por: Du, Xinghua, et al.
Publicado: (2021)

CircRNA RNA hsa_circ_0008234 Promotes Colon Cancer Progression by Regulating the miR-338-3p/ETS1 Axis and PI3K/AKT/mTOR Signaling
por: Wu, Dejun, et al.
Publicado: (2023)

A Circ-0007022/miR-338-3p/Neuropilin-1 Axis Reduces the Radiosensitivity of Esophageal Squamous Cell Carcinoma by Activating Epithelial-To-Mesenchymal Transition and PI3K/AKT Pathway
por: Zhang, Junpeng, et al.
Publicado: (2022)

Effects of Circ_0109046 Regulating Mir-338-3p on the Malignant Behavior of A2780 Cells
por: Zhao, Yue, et al.
Publicado: (2022)

CBX3 promotes clear cell renal carcinoma through PI3K/AKT activation and aberrant immunity
por: Chen, Jiasheng, et al.
Publicado: (2023)

miR-155 Regulates the Proliferation of Glioma Cells Through PI3K/AKT Signaling
por: Wu, Dahao, et al.
Publicado: (2020)

Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma
por: Fan, Demin, et al.
Publicado: (2020)

Mir-338-3p Inhibits Malignant Biological Behaviors of Glioma Cells by Targeting MACC1 Gene
por: Shang, Chao, et al.
Publicado: (2016)

Retracted: Effects of Circ_0109046 Regulating Mir-338-3p on the Malignant Behavior of A2780 Cells
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Loss of SPRR3 in ApoE(-/-) mice leads to atheroma vulnerability through Akt dependent and independent effects in VSMCs
por: Lietman, Caressa D., et al.
Publicado: (2017)

HOXA6 inhibits cell proliferation and induces apoptosis by suppressing the PI3K/Akt signaling pathway in clear cell renal cell carcinoma
por: Wu, Feixiang, et al.
Publicado: (2019)

PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling
por: Wang, Mengmeng, et al.
Publicado: (2023)

miR-206-3p Inhibits 3T3-L1 Cell Adipogenesis via the c-Met/PI3K/Akt Pathway
por: Tang, Renqiao, et al.
Publicado: (2017)

Baicalin suppresses glaucoma pathogenesis by regulating the PI3K/AKT signaling in vitro and in vivo
por: Zhao, Ningmin, et al.
Publicado: (2021)

Down-regulation of miR-424 inhibited the metastasis of endometrial carcinoma via targeting PTEN/PI3K/AKT signaling pathway
por: Lu, Yongwei, et al.
Publicado: (2023)

SPRR3 Contributes to Aggressiveness of Pancreatic Cancer Cells via NF-κB Signaling Pathway
por: Xie, Yuankang, et al.
Publicado: (2023)

FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway
por: Lv, Qi, et al.
Publicado: (2019)

Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
por: Jiang, Ningni, et al.
Publicado: (2020)

Overexpression of 14-3-3σ Modulates Cholangiocarcinoma Cell Survival by PI3K/Akt Signaling
por: Wu, Qiao, et al.
Publicado: (2020)

Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells
por: TIAN, FENG, et al.
Publicado: (2015)

Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells
por: Tian, Feng, et al.
Publicado: (2023)

MiR-5195-3p targets the PCBP2/PI3K/AKT pathway to inhibit melanoma cell proliferation and migration
por: Yang, Botao, et al.
Publicado: (2023)

miR-93 Promotes Cell Proliferation in Gliomas through Activation of PI3K/Akt Signaling Pathway
por: Jiang, Lili, et al.
Publicado: (2015)

Long Noncoding RNA PCAT18 Upregulates SPRR3 to Promote Colorectal Cancer Progression by Binding to miR-759
por: Yang, Daqing, et al.
Publicado: (2020)

MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling
por: Huang, Na, et al.
Publicado: (2015)

The hsa_circ_0039857/miR-338-3p/RAB32 axis promotes the malignant progression of colorectal cancer
por: Xu, Pei, et al.
Publicado: (2022)

AQP3-Dependent PI3K/Akt Modulation in Breast Cancer Cells
por: Mlinarić, Monika, et al.
Publicado: (2023)

CircHIPK3 Facilitates the G2/M Transition in Prostate Cancer Cells by Sponging miR-338-3p
por: Liu, Fengchun, et al.
Publicado: (2020)

Activation of the PI3K/AKT Pathway in Merkel Cell Carcinoma
por: Hafner, Christian, et al.
Publicado: (2012)

Identification of SPRR3 as a novel diagnostic/prognostic biomarker for oral squamous cell carcinoma via RNA sequencing and bioinformatic analyses
por: Yu, Lu, et al.
Publicado: (2020)

Resibufogenin inhibits the malignant characteristics of multiple myeloma cells by blocking the PI3K/Akt signaling pathway
por: Zhou, Yan, et al.
Publicado: (2022)

Alisol A attenuates malignant phenotypes of colorectal cancer cells by inactivating PI3K/Akt signaling
por: Han, Weiwei, et al.
Publicado: (2022)

FAP promotes clear cell renal cell carcinoma progression via activating the PI3K/AKT/mTOR signaling pathway
por: Jiang, Kun, et al.
Publicado: (2023)

TRIM14 regulates melanoma malignancy via PTEN/PI3K/AKT and STAT3 pathways
por: Chen, Jiangyan, et al.
Publicado: (2021)

Medroxyprogestogen enhances apoptosis of SKOV-3 cells via inhibition of the PI3K/Akt signaling pathway
por: Li, Yan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_cgfrq8sc7d087bv1h4vlb153b8